Compare PDLB & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDLB | CYRX |
|---|---|---|
| Founded | 1960 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.0M | 419.3M |
| IPO Year | 2021 | 2008 |
| Metric | PDLB | CYRX |
|---|---|---|
| Price | $17.53 | $9.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 49.7K | ★ 406.1K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.87 | 156.22 |
| EPS | 1.20 | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | $14.68 | ★ $6.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.88 | $5.21 |
| 52 Week High | $18.01 | $11.45 |
| Indicator | PDLB | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.59 | 70.69 |
| Support Level | $15.84 | $9.18 |
| Resistance Level | $18.01 | $10.23 |
| Average True Range (ATR) | 0.36 | 0.42 |
| MACD | 0.10 | 0.19 |
| Stochastic Oscillator | 81.94 | 88.01 |
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.